KRONOS WORLDWIDE INC (KRO) 11.75 -0.18 (-1.51%)
11.75 -0.18 (-1.51%)
US50105F1057 - Common Stock - After market: 11.75 0 (0%)
Fundamental Rating
Overall KRO gets a fundamental rating of 6 out of 10. We evaluated KRO against 123 industry peers in the Chemicals industry. While KRO has a great health rating, its profitability is only average at the moment. A decent growth rate in combination with a cheap valuation! Better keep an eye on KRO.
Profitability
Profitability Rating
KRO has a good Piotroski-F score of 7.00. This indicates a good health and good profitability for KRO.
KRO's Return On Assets of 8.03% is in line with the rest of the industry. The industry average Return On Assets is 7.72%.
KRO has a Return On Equity of 17.75%. This is comparable to the industry average of 19.26%.
KRO's Profit Margin of 7.49% is worse than the rest of the industry. The industry average Profit Margin is 8.37%.
VS Industry
ROA (8.03%) VS Industry: 55% outperformed.
0.04
624.60
ROE (17.75%) VS Industry: 49% outperformed.
0.05
225.47
Profit Margin (7.49%) VS Industry: 38% outperformed.
0.06
85.23
Valuation
Valuation Rating
With a Price/Earnings Ratio of 8.64, the valuation of KRO can be described as very reasonable.
KRO's Price/Earning Ratio is a bit cheaper than the industry average which is at 12.52.
KRO's low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
When comparing the price book ratio of KRO to the average industry price book ratio of 2.22, KRO is valued rather cheaply.
Compared to an average industry Enterprise Value to EBITDA ratio of 9.37, KRO is valued rather cheaply
With a price book ratio of 1.54, KRO is valued correctly.
The Forward Price/Earnings Ratio of 29.33 indicates a quite expensive current valuation of KRO.
VS Industry
Price/Earnings (8.64) VS Industry: 69% outperformed.
602.17
2.06
Price/Book (1.54) VS Industry: 73% outperformed.
764.36
0.03
Enterprise Value/ EBITDA (5.3) VS Industry: 74% outperformed.
13,692.96
1.68
Growth
Growth Rating
KRO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 72.15%, which is quite impressive.
KRO shows a strong growth in Earnings Per Share. Measured over the last 5 years, the EPS has been growing by 22.87% yearly.
The Revenue has grown by 12.13% in the past year. This is quite good.
The Earnings Per Share is expected to grow by 5.83% on average over the next 5 years.
KRO shows a small growth in Revenue. Measured over the last 5 years, the Revenue has been growing by 7.29% yearly.
The Revenue is expected to decrease by -1.34% on average over the next 5 years.
When comparing the EPS growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.
The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.
| Past | Future | ||||||
|---|---|---|---|---|---|---|---|
| 5Y | 3Y | 1Y | 1Y | 2Y | 3Y | 5Y | |
| EPS | 22.87% | -17.89% | 72.15% | -1.75% | -36.06% | 5.83% | N/A |
| Revenue | 7.29% | 5.28% | 12.13% | 4.44% | -4% | -1.34% | N/A |
Health
Health Rating
A Current Ratio of 3.81 indicates that KRO has no problem at all paying its short term obligations.
When comparing the Current Ratio to an average industry Current Ratio of 2.07, KRO is better placed than the average industry peer to meet its short term obligations.
KRO has a Quick Ratio of 2.26. This indicates that KRO is financially healthy and has no problem in meeting its short term obligations.
KRO is better placed than average in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 1.33.
KRO has a good Piotroski-F score of 7.00. This indicates a good health and good profitability for KRO.
The Debt to Equity ratio of KRO is in line with the industry averages.
KRO has an Altman-Z score of 2.73. This is not the best score and indicates that KRO is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score is in line with the industry averages, which is at 2.69.
VS Industry
Debt/Equity (0.44) VS Industry: 57% outperformed.
19.13
0.00
Quick Ratio (2.26) VS Industry: 75% outperformed.
0.01
65.94
Current Ratio (3.81) VS Industry: 80% outperformed.
0.01
65.94
Altman-Z (2.73) VS Industry: 51% outperformed.
-4,753.15
145.35
Dividend
Dividend Rating
KRO has a Yearly Dividend Yield of 6.97%, which is a nice return.
Compared to an average industry Dividend Yield of 2.22, KRO pays a better dividend. On top of this KRO pays more dividend than 88% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, KRO pays a better dividend.
KRO has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of KRO has a limited annual growth rate of 1.92%.
KRO pays out 55.51% of its income as dividend. This is a bit on the high side, but may be sustainable.
The Dividend Rate of KRO has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
VS Industry
Dividend Yield (6.97%) VS Industry: 88% outperformed.
0.30
22.94
KRONOS WORLDWIDE INC11.75
NYSE:KRO (2/3/2023, 7:04:00 PM)-0.18 (-1.51%)
| GICS Sector | Materials | ||
| GICS IndustryGroup | Materials | ||
| GICS Industry | Chemicals | ||
| Earnings (Last) | 11-02 2022-11-02/amc | Earnings (Next) | 03-07 2023-03-07/amc |
| Inst Owners | 16.07% | Inst Owner Change | -0.19% |
| Ins Owners | 0.1% | Ins Owner Change | 1.78% |
| Market Cap | 1.36B | Analysts | 46 |
| Price Target | 10.2 (-13.19%) | ||
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.97% |
| Dividend Growth(5Y) | 1.92% | DP | 55.51% |
| Div Incr Years | 1 | Div Non Decr Years | 10 |
| Ex-Date | N/A | ||
| EPS beat(2) | 1 | Avg EPS beat(2) | 22.26% |
| Min EPS beat(2) | -17.49% | Max EPS beat(2) | 62.02% |
| EPS beat(4) | 3 | Avg EPS beat(4) | 34.15% |
| Min EPS beat(4) | -17.49% | Max EPS beat(4) | 83.35% |
| Revenue beat(2) | 1 | Avg Revenue beat(2) | -1.42% |
| Min Revenue beat(2) | -6.11% | Max Revenue beat(2) | 3.27% |
| Revenue beat(4) | 3 | Avg Revenue beat(4) | 1.99% |
| Min Revenue beat(4) | -6.11% | Max Revenue beat(4) | 10.58% |
| PT rev (1m) | 0% | PT rev (3m) | 3.45% |
| EPS NQ rev (1m) | 0% | EPS NQ rev (3m) | -800% |
| EPS NY rev (1m) | 0% | EPS NY rev (3m) | -16.74% |
| Revenue NQ rev (1m) | 0% | Revenue NQ rev (3m) | -28.45% |
| Revenue NY rev (1m) | 0% | Revenue NY rev (3m) | -4.83% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.64 | ||
| Fwd PE | 29.33 | ||
| P/S | 0.65 | ||
| P/FCF | 18.71 | ||
| P/OCF | 9.72 | ||
| P/B | 1.54 | ||
| P/tB | 1.54 | ||
| EV/EBITDA | 5.3 |
| EPS(TTM) | 1.36 | EY | 11.57% |
| EPS(NY) | 0.4 | Fwd EY | 3.41% |
| FCF(TTM) | 0.63 | FCFY | 5.34% |
| OCF(TTM) | 1.21 | OCFY | 10.29% |
| SpS | 18.05 | BVpS | 7.61 |
| TBVpS | 7.61 | PEG (NY) | N/A |
| PEG (5Y) | 0.38 | ||
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.03% | ||
| ROE | 17.75% | ||
| ROIC | 10.17% | ||
| ROICexc | 12.88% | ||
| ROICexgc | 12.88% | ||
| OM | 10.26% | ||
| PM | 7.49% | ||
| GM | 22.67% |
| ROICexgc(3y) | 8.59% | ROICexcg growth 3Y | -17.2% |
| ROICexcg growth 5Y | 8.73% | ROICexc(3y) | 8.59% |
| ROICexc growth 3Y | -17.2% | ROICexc growth 5Y | 8.73% |
| OM growth 3Y | -20.82% | OM growth 5Y | 8.27% |
| PM growth 3Y | -22.14% | PM growth 5Y | 12.9% |
| GM growth 3Y | -12.06% | GM growth 5Y | 3.47% |
| F-Score | 7 | Asset Turnover | 1.07 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.44 | ||
| Debt/FCF | 5.41 | ||
| Debt/EBITDA | 1.47 | ||
| Cap/Depr | 128.54% | ||
| Profit Quality | 46.47% | ||
| Current Ratio | 3.81 | ||
| Quick Ratio | 2.26 | ||
| Altman-Z | 2.73 |
| F-Score | 7 | WACC | 9.14% |
| ROIC/WACC | 1.41 | Cap/Depr(3y) | 112.29% |
| Cap/Depr(5y) | 121.24% | Profit Quality(3y) | 104.64% |
| Profit Quality(5y) | 87.63% | ||
| EPS 1Y | 72.15% | EPS 3Y | -17.89% |
| EPS 5Y | 22.87% | EPS growth Q2Q | -41.94% |
| EPS Next Y | -1.75% | EPS Next 2Y | -36.06% |
| EPS Next 3Y | 5.83% | EPS Next 5Y | N/A |
| Revenue growth 1Y | 12.13% | Revenue growth 3Y | 5.28% |
| Revenue growth 5Y | 7.29% | Revenue growth Q2Q | -8.04% |
| Revenue Next Year | 4.44% | Revenue Next 2Y | -4% |
| Revenue Next 3Y | -1.34% | Revenue Next 5Y | N/A |
| EBIT growth 1Y | 32.22% | EBIT growth 3Y | -16.64% |
| EBIT growth 5Y | 16.16% | EBIT Next Year | 27.46% |
| EBIT Next 3Y | 14.2% | EBIT Next 5Y | N/A |
| FCF growth 1Y | 117.07% | FCF growth 3Y | 3.81% |
| FCF growth 5Y | 32.22% | OCF growth 1Y | 50.76% |
| OCF growth 3Y | 3.09% | OCF growth 5Y | 18.17% |
Fundamental Stock Screener Links
Fundamental Stock Screener
Find stocks with similar Fundamental rating on the USA
Best Fundamental Competitors Stock Screener
Find the competitors with the best fundamentals on the USA
Best Valuation Competitors Stock Screener
Find the competitors with the best valuation on the USA
Best Dividend Competitors Stock Screener
Find the competitors with the best dividend on the USA